What is the significance of vortex vein invasion in uveal melanoma?

Eye

Volumn 23, Issue 8, 2009, Pages 1661-1667

  Raoof, N ^a   Rennie, I G ^b   Salvi, S M ^a   Sisley, K ^b   Caine, A ^a   Mudhar, H S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Extra ocular extension; Prognostic factors; Scleral invasion; Uveal melanoma; Vortex vein

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER INVASION; CANCER SURVIVAL; CHOROID; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIOID CELL; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; PROGNOSIS; SPINDLE CELL; TUMOR GROWTH; TUMOR VOLUME; UVEA MELANOMA; VEIN DIAMETER;

AGED; AGED, 80 AND OVER; CHOROID; EYE ENUCLEATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; RISK FACTORS; SURVIVAL ANALYSIS; TUMOR BURDEN; UVEAL NEOPLASMS; VEINS;

EID: 69049101411     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.345     Document Type: Article

References (17)

1. Ries LAG, Eisner MP, Kosary CL et al. SEER cancer statistics review, 1973-1999. National Cancer Institute. Bethesda, MD http://seer.cancer.gov/csr/ 1973-1999/, 2002.
2. Shields JA, Shields CL, Donoso LA. Management of posterior uveal melanoma. Surv Ophthalmol 1991; 36: 161-195.
3. COMS. Assessment of metastatic disease status at death in 45 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 2001; 119: 670-676.
4. Kath R, Havungs J, Bornfield N, Sauerwein W, Hoffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993; 72: 2219-2223. (Pubitemid 23280150)
5. Gragoudos ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991; 98: 383-389.
6. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983; 101: 1894-1899. (Pubitemid 14249570)
7. Shields CL, Shields JA, Materin M, Gershbaum E, Singh AD, Smith A. Iris melanoma: risk factors in 169 consecutive cases. Ophthalmology 2001; 108: 172-178.
8. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992; 110: 245-250.
9. McLean IW, Foster WD, Zimmermann LE. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol 1982; 13: 123-132.
10. Folberg R, Pe'er J, Grumn LM, Woolson RF, Jeng G, Montague PR et al. The morphologic characteristics of tumour blood vessels as a marker of tumour progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 1992; 23: 1298-1305.
11. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J et al. The prognostic value of tumour blood vessel morphology in primary uveal melanoma. Ophthalmology 1993; 100: 1389-1398.
12. Seddon JM, Polivogianis L, Hsieh CC, Albert DM, Gamel JW, Gragoudas ES. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch. Ophthalmol. 1987; 105: 801-806.
13. McGurdy J, Gamel J, McClean I. A simple, efficient, and reproducible method for predicting the malignant potential of uveal melanoma for routine H & E slide. Pathol Res Pract 1991; 187: 1025-1027.
14. Prescher G, Bornfold N, Hirche H, Horsthemke B, Karl-Heinz J, Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996; 347: 1222-1225. (Pubitemid 26131850)
15. White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 1998; 83: 354-359.
16. COMS. Histopathologic characteristics of uveal melanoma in eyes enucleated from the Collaborative Ocular Melanoma Study COMS report no. 6. Am J Ophthalmol 1998; 125: 745-766.
17. Patel KA, Edmondson ND, Talbot F, Parsons MA, Rennie IG, Sisley K. Prediction of prognosis inpatients with uveal melanoma using fluorescence in situ hybridization. Br J Ophthalmol 2001; 85: 1440-1444. (Pubitemid 34032910)